A detailed history of Us Bancorp \De\ transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 650 shares of SANA stock, worth $1,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares
650
Previous 855 23.98%
Holding current value
$1,696
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.76 - $6.86 $770 - $1,406
-205 Reduced 23.98%
650 $2,000
Q2 2024

Aug 06, 2024

BUY
$5.23 - $10.44 $2,735 - $5,460
523 Added 157.53%
855 $4,000
Q4 2023

Feb 09, 2024

BUY
$2.8 - $4.55 $929 - $1,510
332 New
332 $1,000
Q1 2023

May 09, 2023

BUY
$3.11 - $4.92 $13,068 - $20,673
4,202 New
4,202 $13,000
Q3 2021

Nov 10, 2021

SELL
$16.29 - $25.88 $342 - $543
-21 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$16.65 - $32.14 $133 - $257
8 Added 61.54%
21 $0
Q1 2021

Apr 28, 2021

BUY
$23.04 - $43.5 $299 - $565
13 New
13 $0

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $497M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.